FPF
First Pacific Financial Portfolio holdings
AUM
$678M
1-Year Return
10.2%
This Quarter Return
+4.97%
1 Year Return
+10.2%
3 Year Return
+40.56%
5 Year Return
+72.73%
10 Year Return
–
AUM
$358M
AUM Growth
+$30.6M
(+9.3%)
Cap. Flow
+$15.6M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
56.96%
Holding
449
New
67
Increased
209
Reduced
73
Closed
26
Top Buys
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$1.78M |
| 2 |
iShares Russell 1000 ETF
IWB
|
$1.25M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$1.04M |
| 4 |
iShares Global REIT ETF
REET
|
$808K |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
$759K |
Sector Composition
| 1 | Technology | 6.73% |
| 2 | Industrials | 3.34% |
| 3 | Consumer Staples | 2.8% |
| 4 | Financials | 2.35% |
| 5 | Healthcare | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vanguard Mortgage-Backed Securities ETF
VMBS
$14.8B
| $7.57K | ﹤0.01% |
+166
| New | +$7.57K |
|
277
Cadence Design Systems
CDNS
$95.6B
| $7.47K | ﹤0.01% |
24
+6
| +33% | +$1.87K |
|
278
Dolby
DLB
$6.96B
| $7.46K | ﹤0.01% |
89
+25
| +39% | +$2.09K |
|
279
Snap-on
SNA
$17.1B
| $7.41K | ﹤0.01% |
25
+7
| +39% | +$2.07K |
|
280
Sempra
SRE
$52.9B
| $7.33K | ﹤0.01% |
+102
| New | +$7.33K |
|
281
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $7.31K | ﹤0.01% |
146
+22
| +18% | +$1.1K |
|
282
General Dynamics
GD
$86.8B
| $7.06K | ﹤0.01% |
+25
| New | +$7.06K |
|
283
iShares 20+ Year Treasury Bond ETF
TLT
$48.9B
| $6.81K | ﹤0.01% |
72
+50
| +227% | +$4.73K |
|
284
BJs Wholesale Club
BJ
$12.8B
| $6.73K | ﹤0.01% |
89
+25
| +39% | +$1.89K |
|
285
Abbott
ABT
$231B
| $6.71K | ﹤0.01% |
+59
| New | +$6.71K |
|
286
TRI-Continental Corp
TY
$1.76B
| $6.5K | ﹤0.01% |
211
| – | – |
|
287
iShares Core Total USD Bond Market ETF
IUSB
$34.2B
| $6.47K | ﹤0.01% |
142
| – | – |
|
288
CDW
CDW
$22.2B
| $6.4K | ﹤0.01% |
25
+7
| +39% | +$1.79K |
|
289
Aon
AON
$79.9B
| $6.34K | ﹤0.01% |
19
+5
| +36% | +$1.67K |
|
290
Aflac
AFL
$57.2B
| $6.27K | ﹤0.01% |
73
+20
| +38% | +$1.72K |
|
291
Amgen
AMGN
$153B
| $6.26K | ﹤0.01% |
22
| – | – |
|
292
J.M. Smucker
SJM
$12B
| $6.17K | ﹤0.01% |
+49
| New | +$6.17K |
|
293
GE HealthCare
GEHC
$34.6B
| $5.64K | ﹤0.01% |
62
+17
| +38% | +$1.55K |
|
294
Colgate-Palmolive
CL
$68.8B
| $5.4K | ﹤0.01% |
+60
| New | +$5.4K |
|
295
Akamai
AKAM
$11.3B
| $5.22K | ﹤0.01% |
48
+14
| +41% | +$1.52K |
|
296
Interpublic Group of Companies
IPG
$9.94B
| $5.09K | ﹤0.01% |
156
+44
| +39% | +$1.44K |
|
297
Dare Bioscience
DARE
$29M
| $4.9K | ﹤0.01% |
833
| – | – |
|
298
Neurocrine Biosciences
NBIX
$14.3B
| $4.69K | ﹤0.01% |
34
+10
| +42% | +$1.38K |
|
299
Avnet
AVT
$4.49B
| $4.66K | ﹤0.01% |
94
+27
| +40% | +$1.34K |
|
300
Reinsurance Group of America
RGA
$12.8B
| $4.63K | ﹤0.01% |
24
+7
| +41% | +$1.35K |
|